0 01/09/2024 31/08/2025 2025-08-31 false false false false false false false true false false true false false false false false false false No description of principal activities is disclosed 2024-09-01 Sage Accounts Production 25.0 - FRS102_2025 xbrli:pure xbrli:shares iso4217:GBP 05544046 2024-09-01 2025-08-31 05544046 2025-08-31 05544046 2024-08-31 05544046 2023-09-01 2024-08-31 05544046 2024-08-31 05544046 2023-08-31 05544046 bus:RegisteredOffice 2024-09-01 2025-08-31 05544046 bus:LeadAgentIfApplicable 2024-09-01 2025-08-31 05544046 bus:Director1 2024-09-01 2025-08-31 05544046 bus:Director2 2024-09-01 2025-08-31 05544046 bus:CompanySecretary1 2024-09-01 2025-08-31 05544046 core:WithinOneYear 2025-08-31 05544046 core:WithinOneYear 2024-08-31 05544046 core:AfterOneYear 2025-08-31 05544046 core:AfterOneYear 2024-08-31 05544046 bus:Director1 2024-08-31 05544046 bus:Director1 2025-08-31 05544046 bus:Director1 2023-08-31 05544046 bus:Director1 2024-08-31 05544046 bus:Director1 2023-09-01 2024-08-31 05544046 bus:Micro-entities 2024-09-01 2025-08-31 05544046 bus:AuditExempt-NoAccountantsReport 2024-09-01 2025-08-31 05544046 bus:SmallCompaniesRegimeForAccounts 2024-09-01 2025-08-31 05544046 bus:PrivateLimitedCompanyLtd 2024-09-01 2025-08-31 05544046 bus:FullAccounts 2024-09-01 2025-08-31
Company registration number: 05544046
Steripharm (UK) Limited
Unaudited filleted financial statements
31 August 2025
Steripharm (UK) Limited
Contents
Directors and other information
Statement of financial position and notes to the financial statements
Steripharm (UK) Limited
Directors and other information

| Directors | Mr Jayaprasad Kaippallil Raman Pillai
|  | Mrs Rajalakshmi Jayaprasad
| Secretary | Mr Jayaprasad Kaippallil Raman Pillai
| Company number | 05544046
| Registered office | Amba House, 4th Floor, Kings Suite
|  | 15 College Road
|  | Harrow
|  | Middlesex
|  | HA1 1BA
| Accountants | Nagle James Associates Limited
|  | Amba House, 4th Floor, Kings Suite
|  | 15 College Road
|  | Harrow
|  | Middlesex
|  | HA1 1BA

Steripharm (UK) Limited
Statement of financial position
31 August 2025

|  |  | 2025 |  | 2024 |  |
|  |  | £ |  | £ |  |
Fixed assets |  |  | 51 |  | 68 |  |
|  |  | _______ |  | _______ |  |
Current assets |  |  | - |  | 1,006 |  |
Creditors: amounts falling due within one year |  |  | ( 61,690) |  | ( 59,833) |  |
|  |  | _______ |  | _______ |  |
Net current liabilities |  |  | ( 61,690) |  | ( 58,827) |  |
|  |  | _______ |  | _______ |  |
Total assets less current liabilities |  |  | ( 61,639) |  | ( 58,759) |  |
Creditors: amounts falling due after more than one year |  |  | ( 970,000) |  | ( 970,000) |  |
Accruals and deferred income |  |  | ( 2,196) |  | ( 3,913) |  |
|  |  | _______ |  | _______ |  |
Net liabilities |  |  | ( 1,033,835) |  | ( 1,032,672) |  |
|  |  | _______ |  | _______ |  |
Capital and reserves |  |  | ( 1,033,835) |  | ( 1,032,672) |  |
|  |  | _______ |  | _______ |  |

Notes to the financial statements
Steripharm (UK) Limited
Year ended 31 August 2025
1. Directors advances, credits and guarantees

| During the year the directors entered into the following advances and credits with the company: |  |  |  |  |  |
2025 |  |  |  |  |  |  |
|  | Balance brought forward | Advances /(credits) to the directors | Balance o/standing |  |  |
|  | £ | £ | £ |  |  |
| Mr Jayaprasad Kaippallil Raman Pillai | ( 5,447) | ( 1,857) | ( 7,304) |  |  |
|  | _______ | _______ | _______ |  |  |
2024 |  |  |  |  |  |  |
|  | Balance brought forward | Advances /(credits) to the directors | Balance o/standing |  |  |
|  | £ | £ | £ |  |  |
| Mr Jayaprasad Kaippallil Raman Pillai | ( 3,447) | ( 2,000) | ( 5,447) |  |  |
|  | _______ | _______ | _______ |  |  |

2. Going Concern
The company has continued support from the shareholders based on that the accounts have been prepared on a going concern basis.
For the year ending 31 August 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors responsiblities:
- The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
The financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the board of directors and authorised for issue on 23 April 2026 , and are signed on behalf of the board by:
Mr Jayaprasad Kaippallil Raman Pillai
Director
Company registration number: 05544046
The company is a private company limited by shares, registered in England & Wales.